These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6820877

  • 1. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
    Satoh S, Suzuki A, Okamura H, Nishimura T.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):140-5. PubMed ID: 6820877
    [Abstract] [Full Text] [Related]

  • 2. [A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432].
    Tsuji H, Sawada S, Okano R, Shimazaki C, Nakanishi S, Haruyama H, Isemura T, Nakagawa M, Ijichi H, Ueda K.
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1851-5. PubMed ID: 6964031
    [Abstract] [Full Text] [Related]

  • 3. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
    Tamura T, Miyamoto H, Harada M, Makinoya T, Yamamoto M, Miyoshi Y, Komi N.
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
    [Abstract] [Full Text] [Related]

  • 4. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Hattori H, Mikuriya S, Mamiya T, Hatano K, Shiina T, Yamada T.
    Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
    [Abstract] [Full Text] [Related]

  • 5. [Local injection of OK-432 and mitomycin C into vulvar cancer responding poorly to bleomycin and linac irradiation].
    Yakabe A, Yamashita S, Kinashi N, Ito T.
    Nihon Gan Chiryo Gakkai Shi; 1987 May 20; 22(4):758-62. PubMed ID: 2444661
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
    Komatsu K, Nakamura W.
    C R Seances Soc Biol Fil; 1986 May 20; 180(1):117-20. PubMed ID: 2943364
    [Abstract] [Full Text] [Related]

  • 16. [Local immunotherapy for cancer].
    Hattori T, Niimoto M, Toge T, Hamamoto S, Seto Y, Kameda A, Tomoda S.
    Nihon Geka Gakkai Zasshi; 1984 Sep 20; 85(9):1157-61. PubMed ID: 6503978
    [Abstract] [Full Text] [Related]

  • 17. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
    Sakata Y, Yoshida Y, Komatsu Y, Sugawara K, Nishimura S, Kikuchi K.
    Gan To Kagaku Ryoho; 1982 Jan 20; 9(1):109-15. PubMed ID: 6820875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
    Green MR, Dillman RO, Horton C.
    Cancer Treat Rep; 1980 Jan 20; 64(1):139-42. PubMed ID: 7379047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.